50+ fold scale-up in cGMP manufacture of multi-antigen reactive allogeneic T-cells to permit 25-fold higher dosing than the highest dose infused in prior human trials
Year: 2021
Type: article
Source: Cytotherapy
Authors: M. Srinivasan, S. Val, R. Ulrey, H. Chonchoro, A. Datar, C. Bollard, M. Kuo, M. Peshwa, P. Hanley
Institutions: Children's National, George Washington University
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3160265372